Microsoft Word - 55-62 Chemistry | 55 Ibn Al-Haitham Jour. for Pure & Appl. Sci. IHJPAS https://doi.org/10.30526/31.3.2010 Vol. 31 (3) 2018 Estimation of Pentraxin-3(PTX3) in Rheumatoid Arthritis Males’ patients (with and without) Type II Diabetes Mellitus in Iraq Nashwa S. Sultan Hamza2006n@gmail.com  Anwar F. AL- Taie dr.anwar1979@yahoo.com Department of Chemistry, College of Education for Pure Science Ibn Al-Haitham, University of Baghdad, Baghdad, Iraq Article history: Received 30 August 2018, Accepted 4 September 2018, Published December 2018 Abstract Rheumatoid arthritis is a chronic inflammatory autoimmune disease its etiology is unknown. The classical autoimmune diseases, have adaptive immune genetic associations with autoantibodies and major histocompatibility complex (MHC) class II such as rheumatoid arthritis (RA), diabetes mellitus type two (DM II). Serum of99 males suffering from RA without DMII as group (G1), 45 males suffering from RA with DM II as group (G2) and 40 healthy males as group (G3) were enrolled in this study to estimation of alkaline phosphates (ALP), C-reactive protein (CRP) and Pentraxin-3(PTX). Results showed a highly significant increase in PTX3 levels in G1 and G2 compared to G3 and a significant decrease in G1comparing to G2. Results also revealed a significant increase in CRP levels in G1 and G2 when compared to G3, as well as a significant increase in G2 comparing to G1. Results showed a significant decrease in ALP levels in G1 and G2 while this phrase must no differences was observed betweenG1 and G2and there was no significant positive correlation between PTX3 and ALP in sera of RA males’ patients with and without DM II it be showed in our study. Keywords: Rheumatoid arthritis; Diabetes mellitus; Pentraxin; C-reactive protein; alkaline phosphates; Methotrexate; folic acid omega 3 1. Introduction Pentraxin are a family of evolutionarily conserved pattern-recognition proteins that are acute phase protein made up of five identical subunits. Based on the primary structure of the subunit that produced by immune and structural cells [1]. The Pentraxin are structurally unrelated to the collections and include small Pentraxin such as C-reactive proteins (CRP), serum amyloid protein (SAP) and such as PTX3 [1- 4]. The multifunctional properties of PTX3 can be at least in part explained by its capacity to interact with a number of different ligands a characteristic shared with CRP and serum amyloid protein (SAP) [4]. Recent studies have shown that PTX3 levels elevated in the presence of a bacterial infection [5]. It is a soluble inflammation and innate immunity [1]. Study demonstrated that PTX3 have a role in allergic asthma [6] so several kinds of cell types are confirmed to produce PTX3—vascular endothelial cells, vascular smooth muscle cells and monocytes pattern recognition receptor with non-redundant functions in macrophages. [1]. Acute-phase protein is a group of proteins that are synthesized in greater amounts include C-reactive protein (CRP) in Acute tissue damage, due to trauma Chronic inflammation and Malignant disease, [7, 8]. Acute phase Chemistry | 56 Ibn Al-Haitham Jour. for Pure & Appl. Sci. IHJPAS https://doi.org/10.30526/31.3.2010 Vol. 31 (3) 2018 protein an include C-reactive protein (CRP) which available marker led to. Its concentration that increase 30-fold from a normal value of less than 5 mg/L during the acute phase response, rheumatoid arthritis and Crohn’s disease [9]. Its measurement appears to be both more sensitive and more specific than measurements of the erythrocyte sedimentation rate (ESR) and plasma viscosity in this respect [9, 10]. Alkaline phosphates (ALP) comprise a group of enzymes that catalyze the hydrolysis of phosphate esters in an alkaline environment, generating an organic radical and inorganic phosphate [11]. Alkaline phosphates are derived from a number of different tissues, including the liver, the osteoblasts in bone and the placenta. Plasma activities rise in cholestatic liver disease because ALP synthesis is increased and the enzyme within the bleary tract is regurgitated into plasma [12, 13]. This study aimed to evaluate ofPentraxin-3 (Ptx3) in Iraqi males’ patients suffering from RA with and without DM II. In addition to found correlation relation for ptx3 with ALP in RA patients with DM II and without DM II. 2. Methods 2.1. Patients Study The samples of blood were collected from 188 males with age ranged between (18-67) years were enrolled in this study in medical city hospital in Baghdad, general hospital in Basra, teaching hospital and Al-salaams hospital in Mosul from October 2017 to April 2018.They were divided into three groups as follows: - 1. Rheumatoid arthritis patients without DM II as group one (G1) that consist of (99) males. 2. Rheumatoid arthritis patients with DM II as group two (G2) that consist of (45) males. 3. Healthy control groups as group three (G3) that consist of (40) males. All patients in groups (G1) and (G2) were taking Methotrexate, Folic acid and Omega3 treatment, Smoker patients were excluded from this study ptx3 were estimated by ELASA kit No: YHB 2259Hu from China. CRP estimated by Latex method kit L21-V3 from UK and ALP estimated by a Colorimetric method according to kit from France. EC 3.1.3. 2.2. Statistical Analysis The statistical analysis of this prospective study performed with the Graph Pad Prism® 7 and MicrosoftExcel2013. Numerical data with normal distribution were described as mean and standard deviation, Analysis of variance (ANOVA) used for multiple comparison using least significant difference. Categorical data were described as count and percentage. Chi-square test or fisher exact test used to estimate the association between variables. The lower level of accepted statistical significant difference is bellow or equal to 0.05. Correlation of coefficient used for estimation of correlation between studied variables. Alan C.2007). 3. Results and Discussion Table 1. and Figures 2. and 3. showed levels of ptx3, CRP% and ALP for the studies groups, that results showed a highly significant increase in PTX3 levels in G1 and G2 compared with G3 and no significant decreasing in PTX3levels in G1compared with G2. Results also revealed a highly significant increase in CRP levels in G1 and G2 when compared to G3, as well as a highly significant increase in G2 comparing to G1. Results showed a highly significant decrease in ALP levels in G1 and G2 when compared with G3, and there were a highly significant different between G1 compared with G2. Chemistry | 57 Ibn Al-Haitham Jour. for Pure & Appl. Sci. IHJPAS https://doi.org/10.30526/31.3.2010 Vol. 31 (3) 2018 Table1. Concentrations of Pentraxin3, CRP, and Alp in males’ Iraqi patients and healthy control. P value G3 NO:40 G2 NO:45 G1 NO:99 Groups Parameters G1&G3 G2&G3 G1 & G2 0.001 H.s 0.001 s 0.129 N.S 0.68±0.09 3.02 ± 0.5 2.65 ± 0.78 Ptx3 -µg/ml 0.001 H.s 0.001 H.s 0.001H. s 0% 37.8% 47.2% CRP IU/ml 0.001 H.s 0.001 H.s 0.001H.s 48.95 ± 4.82 28.05± 5.61 22.04 ± 3.776 ALP U/L G1 = RA without DM II, G2=RA with DM II, G3=healthy control S= significant p value, H. s=high significant p value., N. S=non-significant Figure 1. Pentraxin concentration -µg/ml in males Patients and healthy control. Chemistry | 58 Ibn Al-Haitham Jour. for Pure & Appl. Sci. IHJPAS https://doi.org/10.30526/31.3.2010 Vol. 31 (3) 2018 Figure 2. ALP activity U/L, in males’ patients and healthy control. Tables 2. and 3., Figures 2. and 3. showed the level of Pentraxin-3 in sera of the RA patients without and with DMП, respectively. Groups Gg (Baghdad patients), Gb (Basra patients), and Gm (Mosul patients). The results of all groups in these tables and figures represent a highly significant different in PTX3 levels in RA patients without DMII in three cities (Gg, Gb, and Gm), while there were a highly significant different in PTX3 levels in RA patients with DMII between (Gg and Gb) and (Gb and Gm) cities, while there were no significant different between (Gg and Gm) cities when compared with others. The results also show a highly significant different in CRP levels in RA patients without DMII in three cities (Gg, Gb, and Gm) when compared with them. In addition to no significant different in CRP levels in RA patients with DMII between (Gg and Gb) and (Gb and Gm), while there was a significant different in CRP levels in RA patients with DMII between (Gg and Gm) cities. Table 2. concentrations of Pentraxin-3, CRP, and ALP in three major cities of Iraqi patients of RA without DMII. P value Gm Gb Gg Groups Parameters Gg vs. Gm Gb vs. Gm Gg vs. Gb 0.001 H.s 0.001 H. s 0.001H.s 3.75±1.01 1.58±0.5 2.63±0.72 Ptx3 µg/ml 0.001H.s 0.001H. s 0.001H. s 58.33% 43.75% 39.6% CRP IU/ml 0.209 N.s 0.071N.s 0.002 s 22.23 ± 3.60 23.3 ± 4.4 20.59 ± 3.33 ALP U/L Gg=Baghdad patients of RA. without DMП , Gb=Basra patients with RA. without DMП Gm =Mosul patients with RA. without DMП The concentration of PTX3 and CRP were high in RA patient (with and without DMTT) this results lead to expect that (PTX3 and CRP) may be a sensitive indicator of clinical arthritis. Chemistry | 59 Ibn Al-Haitham Jour. for Pure & Appl. Sci. IHJPAS https://doi.org/10.30526/31.3.2010 Vol. 31 (3) 2018 Also, Table 3. and Figure 4. show no significant different in ALP levels in RA patients with DM II between (Gg and Gb) cities, and a highly significant decrease between (Gb and Gm), in addition to a significant different between (Gg and Gm) when compared with them. Table 3. Concentration Pentraxin-3, CRP and ALK.P in Three major cities of Iraqi patients of RA with DM II. P value Gm Gb Gg Groups Parameters Gg vs. Gm Gb vs. Gm Gg vs. Gb 0.831 N.s 0.001H. s 0.0001 H.s 3.71 ± 1.05 1.76 ±0.91 3.59±0.71 Ptx3 µg/ml 0.032.S 0.516N.S 0.663 N.S 26.7% 53.3% 33.3% CRP IU/ML 0.021 s 0.001 H.s 0.153N.s 31.01 ± 4.77 25.31± 3.52 27.75 ± 6.7 ALP U/L Gg=Baghdad patients of RA. with DMП , Gb=Basra patients with RA. with DMП Gm =Mosul patients with RA. with DMП Figure 3. Pentraxin concentration -µg/ml, in males Patients of RA with and without DM II and healthy control. Chemistry | 60 Ibn Al-Haitham Jour. for Pure & Appl. Sci. IHJPAS https://doi.org/10.30526/31.3.2010 Vol. 31 (3) 2018 Figure 4. ALP activity U/Lin males’ patients of RA with and without DM II in three Iraqi cities. Table 4. correlation between PTX-3 and ALP in RA patients with and without DMTT. ALP Without DMTT 0.271 R ptx-3 0.072 P With DMTT 0.04 R ptx-3 0.633 P RA is an inflammatory disease characterized by chronic inflammation of the symposium, particularly of small joints, which of then leads to destruction of at ocular cartilage and juxta auricular one [14]. Table 1. showed the level of pentraxin-3 (PTX3) in sera of G1, G2Results of all groups represent significantly a High levels of PTX3 in G1 and G2 as a compared with G3.Pentraxins are a group of highly conserved as a modulators of inflammatory processes that primarily produced and released by vascular cell wall study revealed that elevation in (PTX3) level in patients with RA due to the PTX3 belongs to a super family of phylogenically conserved multiservice proteins, with includes short and long Pentraxin3. Combination of PTX3 and CRP could serve as better differential diagnostic markers for RA [15]. c-reactive protein a markers of system inflammation elevated CRP levels have also been linked to an incensed risk of later development of diabetes [16]. and it being strongly predicting for the future development of RA in CRP is a sensitive marker of systemic inflammation and is elevated in patients with RA [17]. As the have suggest ALP are most effective in an alkaline medium [14]. Infect the level of serum ALP is increased in disorders characterized by accelerated bone turnover. For a long time, the diagnose is of RA was mainly based on clinical manifest a torn sand ALP may add useful information for assessing fracture risk and for monitoring osteoporosis in RA patient [17]. RA is the main causes of increased level of ALP because affect the wrist and small joints of the body besides the joints [18], but in and present study showing decrease in ALP in patients of RA with and without DMП that is due to all patients taking a Methotrexate a drug for treatment and taking (omega3 and folic acid) [19-20]. Provide that omega 3 influence ALP activities [19]. Methotrexate is the most important drug modifying anti rheumatic for the treatment of RA and currently considered as the central drug for the standard care and the management of RA [21]. Omega 3 is found primarily in fatty fish with high oil content. It's widely used in the treatment of chemotherapy Chemistry | 61 Ibn Al-Haitham Jour. for Pure & Appl. Sci. IHJPAS https://doi.org/10.30526/31.3.2010 Vol. 31 (3) 2018 as a common consist of multidrug regimens [22]. Folic acid As an antagonist agonist which inhibits de novo synthesis of the nucleoside thymidine a prerequisite for DNA synthesis. Folic acid would be useful in reducing toxic manifestations that occur airing long term treatment with low-dose MTX for RA [23]. 4. Conclusions This study is the first that observe the elevation of PTX3 levels in serum of Iraqi male’s RA patients with and without DMП in three cities (Baghdad, Basra and Mosel) therefore indicated that Ptx3 may be a good biomarker for RA with and without DMП. References 1. Shindo, A.; Maki, T.; Mandeville, ET.; Liang, AC.; Egawa, N.; Itoh, K.; Itoh, N.; Borlongan, M.; Holder. J.C.; Chuang, T.T.; McNeish, J.D. Astrocyte-derived Pentraxin-3 supports blood–brain barrier integrity under acute phase of stroke. Stroke. 2016,47,4,1094-1100. 2. Barbati, E.; Specchia, C.; Villella, M.; Rossi, M.L.; Barlera, S.; Bottazzi, B.; Crociati, L.; d’Arienzo, C.; Fanelli, R.; Garlanda, C.; Gori, F. Influence of pentraxin 3 (PTX3) genetic variants on myocardial infarction risk and PTX3 plasma levels. PloS one. 2012, 7, 12, 1-7. 3. Yang, H.S.; Woo. J.E.; Lee, S.J.; Park, S.H.; Woo, J.M. Elevated plasma pentraxin 3 levels are associated with development and progression of diabetic retinopathy in Korean patients with type 2 diabetes mellitus. Investig. Ophthal mol. Vis. Sci. 2014, 55,9, 5989-5997. 4. George, S.J.; Johnson, J. Atherosclerosis: molecular and cellular mechanisms. John Wiley & Sons. 2010. ISBN: 978-3-527-32448-4 5. Thulborn, S.J.; Dilpazir, M.; Haldar, K.; Mistry, V.; Brightling, C. E.; Barer, M.R.; Bafadhel, M. Investigating the role of Pentraxin-3 as a biomarker for bacterial infection in subjects with COPD. Int J Chron Obstruct Pulmon Dis. 2017, 12,1199- 1205. 6. Zhang, J.; Shan, L.; Koussih, L.; Redhu, N.S.; Halayko, A.J.; Chakir, J.; Gounni, A.S. Pentraxin-3 (PTX3) expression in allergic asthmatic airways: role in airway smooth muscle migration and chemokine production. PloS one. 2012, 7, 4, 1-9. 7. Whitby, L.G.; Smith, A.F.; Beckett, G.J. Lecture notes on clinical chemistry. 4th ed. 1988. 8. Dayoub, R.; Buerger, L.; Ibrahim, S.; Melter, M.; Weiss, T.S. Augmenter of liver regeneration (ALR) exhibits a dual signaling impact on hepatic acute-phase response. Exp Mol Pathol Suppl. 2017, 102, 3, 428-433. 9. Du Clos, T.W.; Mold, C. Pentraxins (CRP, SAP) in the process of complement activation and clearance of apoptotic bodies through Fcγ receptors. Current opinion in organ transplantation. 2011, 16, 1, 1-11.  10. Rifai, N.; Horvath, A.R.; Wittwer, C. Tietz. Textbook of clinical chemistry and molecular diagnostics. Elsevier. 2018. 11. Najeeb, Q.; Aziz, R. Comparison of Alkaline phosphatase. Lactate Dehydrogenase and Acid Phosphatase Levels in Serum and Synovial Fluid between Patients with Rheumatoid Arthritis and Osteoarthritis. Int. J. Sci. Res. 2015, 4, 4, 1069-1072. 12. Crook, M. Clinical chemistry & metabolic medicine. London: Hodder Arnold. 2006. Chemistry | 62 Ibn Al-Haitham Jour. for Pure & Appl. Sci. IHJPAS https://doi.org/10.30526/31.3.2010 Vol. 31 (3) 2018 13. Syvolap, V.D.; Nazarenko, E.V. Evaluation data of laboratory and instrumental studies in Gastroenterology. 2017. 14. Abhishek, D.; Daving, H.; Suman, D.; Laljem, H.; Th Ibetombi D. Study of Serum Alkaline Phosphatase Level in Rheumatoid Arthritis. Int J med R. 2017, 3, 3, 318-321. 15. Sharma, A.; Khan, R.; Gupta, N.; Zaheer, M.S.; Abbas, M.; Khan, S.A. Acute phase reactant, Pentraxin-3, as a novel marker for the diagnosis of rheumatoid arthritis. Clin Chim Acta. 2018, 480, 65-70. 16. King, D.E.; Mainous, A.G.; Buchanan, T.A.; Pearson, W.S. C-reactive protein and glycemic control in adults with diabetes. Diabetes care. 2003, 26, 5, 1535-1539. 17. Shadick, N.A.; Cook, N.R.; Karlson, E.W.; Ridker, P.M.; Maher, N.E.; Manson, J.E.; Buring, J.E. Lee I.M. C-reactive protein in the prediction of rheumatoid arthritis in women. Arch Intern Med. 2006, 166, 22, 2490-2494. 18. Chandrakar, B.L.; Harish, C. S.; Chandrakar, K. S. Activity of Serum Alkaline Phosphatase in Rheumatoid Arthritis for Diagnosis and Management. Int J Med Res Prof. 2017, 3,3, 281-284. 19. Shaimaa, S.K. Evaluation of Omega-3Effect as Adjuvant Therapy to Methotrexate on Alkaline Phosphates Level in Iraqi Patients with Active Rheumatoid Arthritis. Tikrit Journal of Pharmaceutical. 2017, 12, 1, 9-16. 20. Namiy, I. H.; Essam N.; Sana,a, H. A. Effect of Type 2 Diabetes Mellitus on Extracellular 21. Superoxide Dismutase: Without Complications among Iraqi Patients. IHJPAS. 2016, 29, 3, 132 - 145. 22. Zhao, N.; Zheng, G.; Li, J.; Zhao, H.Y.; Lu, C.; Jiang, M.; Zhang, C.; Guo, H.T., Lu, A.P. Text mining of rheumatoid arthritis and diabetes mellitus to understand the mechanisms of Chinese medicine in different diseases with same treatment. Chin J Integr Med. 2018, 24, 10, 777-784. 23. Karri, S.; Vanithakumari, G. Impact of Methotrexate and Leucovorin on Hormonal Regulated Enzymes of Carbohydrate Metabolism in Accessory Reproductive Tissues of Ovariectomized Rats. Transl Med. 2012, 2, 2, 1-9. 24. Morgan, S.L.; Baggott, J.E.; Vaughn, W.H.; Young, P.K.; Austin, J.V.; Krumdieck, C.L.; Alarcon, G.S. The effect of folic acid supplementation on the toxicity of low-dose methotrexate in patients with rheumatoid arthritis. Arthritis & Rheumatology. 1990, 33, 1, 9-18.